Your browser doesn't support javascript.
loading
CINSARC in high-risk soft tissue sarcoma patients treated with neoadjuvant chemotherapy: Results from the ISG-STS 1001 study.
Frezza, Anna Maria; Stacchiotti, Silvia; Chibon, Frederic; Coindre, Jean-Michelle; Italiano, Antoine; Romagnosa, Cleofe; Bagué, Silvia; Dei Tos, Angelo Paolo; Braglia, Luca; Palmerini, Emanuela; Quagliuolo, Vittorio; Broto, Javier Martin; Lopez Pousa, Antonio; Grignani, Giovanni; Brunello, Antonella; Blay, Jean-Yves; Beveridge, Robert Diaz; Lugowska, Iwona; Lesluyes, Tom; Maestro, Roberta; Merlo, Franco Domenico; Casali, Paolo Giovanni; Gronchi, Alessandro.
Afiliação
  • Frezza AM; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
  • Stacchiotti S; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
  • Chibon F; Institut Claudius Régaud, Cancer Research Center of Toulouse (CRCT), IUCT- Oncopole, Toulouse, France.
  • Coindre JM; Department of Biopathology, Institut Bergonié, Bordeaux, France.
  • Italiano A; Early Phase Trials and Sarcoma Units, Institut Bergonié, Bordeaux, France.
  • Romagnosa C; Clinical Genetics and Genetic Counseling Program, Germans Trias i Pujol Hospital, Barcelona, Spain.
  • Bagué S; Department of Pathology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Dei Tos AP; Department of Medicine, University of Padua School of Medicine, Padua, Italy.
  • Braglia L; Department Infrastructure Research and Statistics, Azienda USL-IRCCS Reggio Emilia, Reggio Emilia, Italy.
  • Palmerini E; Osteoncology, Bone and Soft Tissue Sarcomas and Innovative Therapies, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
  • Quagliuolo V; Sarcoma, Melanoma and Rare Tumors Surgery Unit, IRCCS Humanitas Research Hospital, Milan, Italy.
  • Broto JM; Medical Oncology Department, University Hospital Fundación Jimenez Diaz, Madrid, Spain, University Hospital General de Villalba, Madrid, Spain. Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (IIS/FJD; UAM), Madrid, Spain.
  • Lopez Pousa A; Fundacio de Gestio Sanitaria de L'Hospital de la Santa Creu I Sant Pau, Barcelona, Spain.
  • Grignani G; Division of Medical Oncology, Candiolo Cancer Institute, FPO - IRCCS, Candiolo, Italy.
  • Brunello A; Medical Oncology, Istituto Oncologico Veneto, Padova, Italy.
  • Blay JY; Department of Medicine, Centre Leon Berard, UNICANCER & University Lyon I, Lyon, France.
  • Beveridge RD; Department of Cancer Medicine, Hospital Universitari i Politècnic La Fe, Valencia, Spain.
  • Lugowska I; Department of Soft Tissue/Bone Sarcoma and Melanoma, Centrum Onkologii, Instytut im. Marii Sklodowskiej-Curie, Warsaw, Poland.
  • Lesluyes T; Institut Claudius Régaud, Cancer Research Center of Toulouse (CRCT), IUCT- Oncopole, Toulouse, France.
  • Maestro R; Oncogenetics and Oncogenomics Unit, Centro di Riferimento Oncologico di Aviano IRCCS, Aviano, Italy.
  • Merlo FD; Scientific Department, Azienda USL-IRCCS Reggio Emilia, Reggio Emilia, Italy.
  • Casali PG; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
  • Gronchi A; Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Cancer Med ; 12(2): 1350-1357, 2023 01.
Article em En | MEDLINE | ID: mdl-35848358

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Sarcoma / Neoplasias de Tecidos Moles Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Med Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Itália